Industry, Business & Agriculture Timetable
Dated 23.10.2020*
Monday, October 26
12:30-12:45
12:30-12:35
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel
12:35-12:40
Mr. Yossi Bornstein
Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel
12:35-12:40
Mr. Yuli (Yoel) Edelstein
Minister of Health, Israel
12:45-13:30
IF WE CANNOT CHANGE THE FUTURE AT LEAST WE CAN CHANGE OUR ATTITUDE
12:45-13:15
Prof. Dedi Meiri
Assistant Professor, Heads the “Laboratory of Cancer Biology and Cannabinoid Research”, Technion, Israel Institute of Technology, Israel
13:15-13:30
Live Discussion/Q&A
14:00-14:45
MEDICAL GRADE CANNABIS: DEFINITIONS AND CONCEPTS
14:00-14:25
Dr. Raquel Peyraube
Executive Committee, the International Association for Cannabinoid Medicines, Uruguay
14:25-14:40
Live Discussion/Q&A
14:45-15:45
CULTIVATING SCIENCE IN THE MEDICAL CANNABIS BUSINESS
14:45-15:00
EMERGING TECHNOLOGIES FOR TESTING AND ANALYZING MEDICAL CANNABIS COMPOUNDS
Joshua Alper
Chief Strategy Officer, Harvest 360 Technologies, USA
15:00-15:05 – Live Q&A with Joshua Alper
15:05-15:20
TLE: CHANGING THE PERCEPTION OF PLANT-BASED MEDICINE BY USING SCIENCE WITH GREENWAY DNA
Clare Navas
CEO & Founder, The Leaf Extract, Spain
15:20-15:25 Live Q&A with Clare Navas
15:25-15:40
SAVE THE TERPS, ORG CANNABIS FLOWER QUALITY SCORING SYSTEM WITH RESPECT TO TERPENOID CONTENT AND WATER ACTIVITY
Andrew Samann
CEO, Orion GMP Solutions, USA
15:40-15:45 Live Q&A with Andrew Samann
16:30-17:30
PANEL DISCUSSION: WOMEN IN THE FOREFRONT OF CANNABIS INNOVATION
16:30-17:20
Moderator:
Mrs. Ma’ayan Weisberg Joels
CEO, Hiliz, Israel
Panelists:
Mrs. Ma’ayan Weisberg Joels
CEO, Hiliz, Israel
Mrs. Iris Bincovich
CEO, InnoCan Pharma, Israel
Mrs. Yona Cymerman
Co-Founder and COO, Can Innovations, Israel
17:20-17:30
Live Discussion/Q&A
18:00-19:00
CELEBRATION OF PROF. MECHOULAM’S 90TH BIRTHDAY
18:00 – 18:10
Birthday Greetings
Mr. Yossi Bornstein
Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel
Mr. Yuli (Yoel) Edelstein
Minister of Health, Israel
Mr. Dan Rivlin
CEO, Kenes Group, Israel
18:10 – 18:20
The Scientist
18:20 – 18:30
A Salute to Prof. Mechoulam’s Outstanding Contribution to Mankind
18:30 – 18:50
Prof. Raphael Mechoulam: Reflections on My Scientific Life – Interview with Dr. Dedi Meiri
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel
Prof. Dedi Meiri
Assistant Professor, Heads the “Laboratory of Cancer Biology and Cannabinoid Research”, Technion, Israel Institute of Technology, Israel
18:50 – 19:00
Live Content
Tuesday, October 27
13:45-14:20
MEET THE EXPERTS: CANNABIS PLANT SCIENCE: INTERPLAY BETWEEN CANNABINOIDS AND ENVIRONMENTAL CONDITIONS
13:45-14:10
Dr. Nirit Bernstein
Ph.D., Senior Research Scientist, ARO, Volcani Institute, Israel
14:10-14:20
Live Discussion/Q&A
ABSTRACT PRESENTATIONS I
14:20-14:30
A PILOT RANDOMISED PLACEBO-CONTROLLED TRIAL OF CANNABIDIOL TO REDUCE SEVERE BEHAVIOURAL PROBLEMS IN CHILDREN AND ADOLESCENTS WITH INTELLECTUAL DISABILITY
Asst. Prof. Daryl Efron, Australia
14:30-14:40
CANNABIS GENE VARIATION – COMPARISON OF MULTIPLE GENOME ASSEMBLIES
Dr. Oori Weisshaus, Israel
14:40-14:50
TREATING HIDRADENITIS SUPPURATIVA (HS) WITH CANNABIS
Mrs. Irit Avisar, Israel
14:50-15:00
CANNABINOIDS AND CBD FOR BEAUTY AND SKIN DISORDERS
Dr. Jeanette Jacknin, United States
15:00-15:10
CAUSE OR EFFECT: INCREASED PREVALENCE OF CANNABIS USE IN INFLAMMATORY BOWEL DISEASE SYSTEMATIC REVIEW OF THE EPIDEMIOLOGICAL EVIDENCE
Dr. Gabor Z. Xantus, United Kingdom
15:10-15:20
CANNABIS MODULATION OF INFLAMMATORY SKIN DISEASES
Dr. Yehuda Baruch, Israel
15:20-15:30
CANNABIDIOL IN ACUTE LOW BACK PAIN – A PROTOCOL AND RATIONALE OF A CLINICAL EFFECTIVENESS TRIAL
Asst. Prof., Anna Gyarmathy, United Kingdom
ABSTRACT PRESENTATIONS II
14:20-14:30
NOVEL DEVICE AND FORMULATION FOR CANNABIS INHALER
Dr. Eran Toledo, Israel
14:30-14:40
INVESTMENTS IN STRATEGY AND DATA ARE THE KEY TO SUCCESS IN EUROPEAN MEDICAL CANNABIS
Mr. TJ Unger
14:40-14:50
NOVEL DELIVERY PLATFORMS FOR CANNABIS-BASED THERAPIES
Dr. Oren Levy
14:50-15:00
THE MECHANISM OF ACTION AND MOLECULAR TARGET OF CANNABIDIOL IN HUMAN GLIOMA
Dr. Chao Yan
15:00-15:10
CANNABIS AND ITS MEDICALLY RELEVANT EFFECTS: AN ONLINE GENOMIC STUDY DESIGN
Dr. Nancy Saccone
15:10-15:20
MEDICAL CANNABIS AS A THERAPEUTIC RESOURCE: PRELIMINARY STUDY
Dr. Mariano Velazquez
15:20-15:30
TBA
15:30-16:30
THE INTERPLAY OF SCIENCE, BUSINESS AND LAW
14:00-14:15
BUSINESS OPPORTUNITIES WITH NEW REGULATIONS IN LATIN AMERICA: THE BRAZILIAN CASE
Alessandra Mourao
Founder, Nascimento e Mourão Advogados, Brazil
14:15-14:20 – Live Q&A with Alessandra Mourao
14:20-14:35
ENGINEERING AND PATENTING LEGAL CANNABIS
Dr. Joseph Mogan
President, Kotzker Consulting, Llc, USA
14:35-14:40 – Live Q&A with Joseph Mogan
14:40-15:00
THE ROAD TO GAP AND GMP ACCREDITATION – PRACTICAL LESSONS LEARNT, AND THE CHALLENGES OF OPERATING FROM A REMOTE LOCATION
Francois Ferreira
CEO, MG Health, Lesotho
14:55 – 15:00 – Live Q&A with Francois Ferreira
17:00-17:45
WORKSHOP: CANNABIS EXTRACTION AND PURIFICATION METHODS: YOU NEED TO FOCUS IN COMPLIANCE AND THE FINAL PRODUCT REQUIRED
17:00-17:35
Dr. Xavier Nadal
Ph.D., Director, EthnoPhytoTech Research & Consulting, Spain
17:35-17:45
Live Discussion/Q&A
17:45-18:45
INTEGRATING SCIENCE AND BUSINESS: A BRAZILIAN PERSPECTIVE
16:45-17:15
AN OVERVIEW ON CANNABINOID MEDICINE
Dr. David Bearman
MD, University of Wisconsin and University of Washington School of Medicine, USA
17:15-17:35
CONTRIBUTIONS OF CANNABIS COMPANIES TO SCIENCE AND MEDICAL EDUCATION IN BRAZIL
Mr. Gabriel Barbosa
MSc in Biotechnology, R&D and Regulatory Supervisor, HempMeds, Brazil
17:35-17:45
Live Discussion/Q&A
Chair: Mrs. Caroline Heinz
Co-CEO, HempMeds, Brazil
Wednesday, October 28
15:30-16:30
ROUND TABLE DISCUSSION: MEDICAL CANNABIS AND THE ROLE OF PHARMACISTS: THE ISRAELI EXPERIENCE
15:30-16:20
Chair: Mrs. Yael Meir
Chief Operating Officer, Cann 10 – Medical Cannabis, Israel
Mr. David Papo
Chair of the Israeli Pharmaceutical Society, Israel
Mr. Liron Goldstein
Telepharma, Israel
16:20-16:30
Live Discussion/Q&A
16:45-17:30
MEET THE EXPERTS: CLINICAL STUDIES AND MEDICAL CANNABIS
Dr. Stephen Levenstein
M.D., VP, Clinical Trials Division, GCP Clinical Studies, Israel
Dr. Hanna Billig
Ph.D., Manager, Drugs Clinical Trials Unit, Israeli MOH, Israel
Dr. Yael Zenziper Straichman
Ph.D., Manager of the Research & Development Unit, IMCA, Israel
17:30-18:45
TOWARDS THE INTEGRATION OF CANNABIS INTO MEDICINE IN THE 21ST CENTURY
17:30-17:50
TUNING THE ENDOCANNABINOID SYSTEM: WHEN TREATMENT MATCHES THE PATIENT
Dr. Fabricio Pamplona
Head of Science – CSO, Proprium Health Technology and Science, Brazil
17:50-18:10
SELECTION AND DOMESTICATION OF CANNABIS STRAINS AS A BASIS FOR MEDICINE DEVELOPMENTS
Prof. Hinanit Koltai
Senior Research Scientist, Agricultural Research Organization, Volcani Center, Israel
18:10-18:30
TOPICAL CANNABIS-BASED MEDICINES (TCBM): A NOVEL PARADIGM FOR INTEGUMENTARY & WOUND MANAGEMENT
Dr. Vincent Maida
Associate Professor, University of Toronto, Canada
18:30-18:45
Live Discussion/ Q&A